| Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25 (NCT06227676) | Cornell University | 2022-07-21 |
| Premenstrual Dysphoric Disorder:Knowledge,Attitude and Practice Among Egyptian Females (NCT05327075) | Al-Azhar University | 2022-03-15 |
| EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders (NCT04123483) | Massachusetts General Hospital | 2019-11-01 |
| Premenstrual Hormonal and Affective State Evaluation (PHASE) Project (NCT03862469) | University of Illinois at Chicago | 2019-09-26 |
| Single Session of tACS in a Depressive Episode (NCT03449979) | University of North Carolina, Chapel Hill | 2018-09-19 |
| A Study of Efficacy and Safety of Sepranolone (UC1010) in Patients With Premenstrual Dysphoric Disorder (PMDD) (NCT03697265) | Asarina Pharma | 2018-04-20 |
| Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder (NCT01217775) | Pherin Pharmaceuticals, Inc. | 2016-03-01 |
| Emotional Processing and Oxytocin Mechanisms in Premenstrual Dysphoric Disorder: A Pilot Study (NCT02508103) | University of North Carolina, Chapel Hill | 2015-07-01 |
| Deep Transcranial Magnetic Stimulation (dTMS) for the Treatment of Premenstrual Dysphoric Disorder (PMDD) (NCT02448836) | Tel-Aviv Sourasky Medical Center | 2015-06-01 |
| Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD (NCT02362191) | University of North Carolina, Chapel Hill | 2015-03-01 |
| Alternative Treatments for Premenstrual Dysphoric Disorder (NCT01799733) | University of California, San Diego | 2013-06-18 |
| A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD) (NCT01875718) | Umecrine Mood AB | 2013-01-01 |
| The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels (NCT01385709) | Weill Medical College of Cornell University | 2008-08-01 |
| Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) (NCT00927095) | University of North Carolina, Chapel Hill | 2008-07-01 |
| Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives (NCT00089414) | National Institute of Mental Health (NIMH) | 2004-07-01 |
| Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) (NCT00518570) | Berkshire Health Systems | 2003-11-01 |
| A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual Dysphoria (NCT00516113) | Karolinska Institutet | 2000-10-01 |
| The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder (NCT00678574) | University of Pennsylvania | 1998-03-01 |
| Luteal Phase Administration of Paroxetine for the Treatment of PMDD (NCT00620581) | Hamilton Health Sciences Corporation | |